MedTrace Logo

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

NCT02132663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 315

Last updated 2015-05-01

No results posted yet for this study

Summary

This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.

Conditions

  • Growth of Term Infants

Interventions

OTHER

Control: Marketed routine infant formula

OTHER

An investigational infant formula containing an alternate source of DHA

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Carol Lynn Berseth, M.D. · Mead Johnson and Company

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
10 Days
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-03-31
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02132663 on ClinicalTrials.gov